Novo Nordisk and Biomarin make peace in strife over employees and confidentiality
A court strife between Novo Nordisk and Biomarin on business secrets and the recruitment of central Novo Nordisk employees has been concluded outside of court, according to Børsen.
BY MIKKEL AABENHUS HEMMINGSEN, TRANSLATED BY NIELSINE NIELSEN
Novo Nordisk and the US-based biotech firm Biomarin have settled their court fight in the battle for the hemophilia market, according to Danish newspaper Børsen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg)
.jpg&w=384&q=75)
